Resumo

PEREZ MEJIA, Camilo Alberto  e  HOLGUIN LEW, Jorge Carlos. Pharmacological Treatment of Neuropsychiatric Disorders in Traumatic Brain Injury. rev.colomb.psiquiatr. [online]. 2007, vol.36, suppl.1, pp.52-62. ISSN 0034-7450.

Introduction: Pharmacological treatment of neuropsychiatric disorders in the patient with traumatic brain injury (TBI) stems from a careful clinical assessment. The patient’s psychopathology, history, environment and factors related to daily living susceptible of being treated non-pharmacologically should be assessed, prior to any pharmacological intervention. Objective: To point out which disorders are directly caused by TBI and which could be possible voluntary or involuntary secondary gains. Method: General aspects of the use of psychopharmacological agents in patients with TBI are described. Conclusions: Symptoms such as mood disorders due to brain damage, apathy, anxiety disorders, etc., need to be identifi ed, treated and followed up periodically. Patients with TBI should be treated by experienced interdisciplinary teams allowing the response to pharmacotherapy to be assessed using clinical tools from cognitive neuroscience from a neuropsychiatric perspective.

Palavras-chave : Craniocerebral trauma; neurology; psychiatry; post-concussion syndrome.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )